Neuren Pharmaceutical's partner Acadia reports boosted sales of the Rett syndrome drug Daybue, but Neuren notes two-thirds of ...

People with a wheat or soy allergy could experience a "serious or life-threatening" reaction if they consume the product.

Key Points Non-GAAP earnings per share (EPS) of $2.25 in Q2 2025 far surpassed the analyst estimate of $0.32 and rose 923% year-over-year compared to Q2 2024 (non-GAAP adjusted diluted EPS per ADS).

For instructions on how to access the free Hawaiʻi Medical Cannabis Course Bundle, click here.

The first aceclidine-based eye drop to improve near vision in adults with presbyopia, which affects more than 100 million ...

Ginger may play a positive role in blood sugar management. Get an expert’s take on the herb’s potential health benefits for people with diabetes, including a reduced HbA1C and more flavorful food ...

In a letter to physicians, the company noted that there is an increased risk of blockages in the bloodstream depending on the ...

CMS often withholds coverage for reimbursement, disrupting the natural flow of the market and hindering access to proven ...

By going after an obscure regulatory designation he describes as a “loophole,” Mr. Kennedy has put an industry he champions ...

Dr. Marty Makary has criticized the Food and Drug Administration for being "captured" by Big Food and Big Pharma. Now, the ...

The Department of Health and Human Services (HHS) is winding down its mRNA vaccine development activities under the Biomedical Advanced Research and Development Authority (BARDA), the agency ...

US Food and Drug Administration Commissioner Marty Makary said he’s trying to persuade Vinay Prasad, the agency’s former head ...